Fazal Khan - Merrimack Pharmaceuticals VP Manufacturing
Insider
Fazal Khan is VP Manufacturing of Merrimack Pharmaceuticals
| Age | 74 |
| Phone | 617 720 8606 |
| Web | https://www.merrimack.com |
Merrimack Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.0107) % which means that it has lost $0.0107 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0112) %, meaning that it created substantial loss on money invested by shareholders. Merrimack Pharmaceuticals' management efficiency ratios could be used to measure how well Merrimack Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| DSc FRSC | Agios Pharm | 76 | |
| Brian MBA | Agios Pharm | 56 | |
| Patrik Florencio | Amicus Therapeutics | N/A | |
| David Clark | Amicus Therapeutics | 49 | |
| Alvin Pharmd | Puma Biotechnology | 71 | |
| Richa Poddar | Agios Pharm | 42 | |
| Andrew Faughnan | Amicus Therapeutics | N/A | |
| T Washburn | Agios Pharm | 43 | |
| Craig MD | Agios Pharm | 72 | |
| Dr DACVP | Agios Pharm | 63 | |
| Cecilia Jones | Agios Pharm | 50 | |
| Jeffrey Ludwig | Puma Biotechnology | 59 | |
| Prof Schlessinger | Celldex Therapeutics | 80 | |
| Diana Moore | Amicus Therapeutics | N/A | |
| ShinSan Su | Agios Pharm | 69 | |
| Anthony MBA | Celldex Therapeutics | 63 | |
Management Performance
| Return On Equity | -0.0112 | |||
| Return On Asset | -0.0107 |
Merrimack Pharmaceuticals Leadership Team
Elected by the shareholders, the Merrimack Pharmaceuticals' board of directors comprises two types of representatives: Merrimack Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merrimack. The board's role is to monitor Merrimack Pharmaceuticals' management team and ensure that shareholders' interests are well served. Merrimack Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merrimack Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fazal Khan, VP Manufacturing | ||
| Timothy Surgenor, Secretary | ||
| Ulrik Nielsen, Chief Scientific Officer and Sr. VP of Research | ||
| Ellen Forest, Head of Human Resources | ||
| Daryl Drummond, Head of Research | ||
| MBA MBA, Treasurer and President | ||
| Gary MBA, Treasurer and Presidentident | ||
| ScD Sinskey, CoFounder Advisor | ||
| Geoffrey CFA, Director Communications |
Merrimack Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merrimack Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0112 | |||
| Return On Asset | -0.0107 | |||
| Current Valuation | (20.36 M) | |||
| Shares Outstanding | 14.79 M | |||
| Shares Owned By Insiders | 1.19 % | |||
| Shares Owned By Institutions | 62.97 % | |||
| Number Of Shares Shorted | 842.49 K | |||
| Price To Earning | 65.70 X | |||
| Price To Book | 11.38 X | |||
| Gross Profit | (9.1 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |